novelmed.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home - |
| Description | Partnering NovelMed About Us R & D Strategy Product Pipeline Partners Contact Us Careers News Transforming lives of patients with rare diseases First-in-class treatm |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 13.248.155.104 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
novelmed.com Valuation
|
US$1,052,299
Last updated: 2023-04-28 22:57:45
novelmed.com has Semrush global rank of 10,058,272. novelmed.com has an estimated worth of US$ 1,052,299, based on its estimated Ads revenue. novelmed.com receives approximately 121,420 unique visitors each day. Its web server is located in United States, with IP address 13.248.155.104. According to SiteAdvisor, novelmed.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,052,299 |
| Daily Ads Revenue | US$972 |
| Monthly Ads Revenue | US$29,141 |
| Yearly Ads Revenue | US$349,687 |
| Daily Unique Visitors | 8,095 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| novelmed.com. | A | 7200 | IP: 13.248.155.104 |
| novelmed.com. | A | 7200 | IP: 76.223.27.102 |
| novelmed.com. | NS | 7200 | NS Record: ns67.worldnic.com. |
| novelmed.com. | NS | 7200 | NS Record: ns68.worldnic.com. |
| novelmed.com. | MX | 3600 | MX Record: 10 novelmed-com.mail.protection.outlook.com. |
| novelmed.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| novelmed.com. | TXT | 3600 | TXT Record: MS=ms66257589 |
HtmlToTextCheckTime:2023-04-28 22:57:45
| NovelMed About Us R & D Strategy Product Pipeline Partners Contact Us Careers News Transforming lives of patients with rare diseases First-in-class treatment for hemolytic disorders (PNH) New drug for patients with rare kidney diseases Science matters....Innovation matters Reaching out to unknowns via innovation Pioneering treatments for unmet needs Therapies for unsolved mysteries of eye diseases Partnering Opportunities Who We Are We are pioneers in the field of complement-mediated rare diseases. Our scientists are focused on discovering novel therapies for rare diseases in which the complement alternative pathway is a key driver of pathogenesis. Unlike C5 blockers in the complement space, we focus on therapies that can intervene upstream in the complement system, selectively targeting the underlying pathway of each disease in question. One drug can target many diseases. We are continuously motivated by the needs of patients as we discover unique therapies for rare diseases. Every |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Thu, 21 Oct 2021 21:39:37 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://www.novelmed.com/ HTTP/2 200 server: openresty date: Thu, 21 Oct 2021 21:39:37 GMT content-type: text/html content-length: 11053 accept-ranges: bytes via: 1.1 varnish age: 0 x-served-by: cache-dca17750-DCA x-cache: MISS x-cache-hits: 0 x-timer: S1634852377.324840,VS0,VE98 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
novelmed.com Whois Information
Domain Name: NOVELMED.COM Registry Domain ID: 87579135_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-09-09T16:03:52Z Creation Date: 2002-06-16T03:34:00Z Registry Expiry Date: 2024-06-16T03:34:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS67.WORLDNIC.COM Name Server: NS68.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T16:37:35Z <<< |